HIV-2EU: Supporting standardized HIV-2 drug resistance interpretation in europe

32Citations
Citations of this article
40Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Considering human immunodeficiency virus type 2 (HIV-2) phenotypic data and experience from HIV type 1 and from the follow-up of HIV-2-infected patients, a panel of European experts voted on a rule set for interpretation of mutations in HIV-2 protease, reverse transcriptase, and integrase and an automated tool for HIV-2 drug resistance analyses freely available on the Internet (http://www.hiv-grade.de). © 2013 The Author.

Cite

CITATION STYLE

APA

Charpentier, C., Camacho, R., Ruelle, J., Kaiser, R., Eberle, J., Gürtler, L., … Obermeier, M. (2013). HIV-2EU: Supporting standardized HIV-2 drug resistance interpretation in europe. Clinical Infectious Diseases, 56(11), 1654–1658. https://doi.org/10.1093/cid/cit104

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free